Imexpharm Corp operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imexpharm Corp with three other
companies in this sector in Vietnam:
Hatay Pharmaceutical JSC
sales of 1.48 trillion Dong [US$64.99 million]
DOMESCO Medical Import Export Joint Stock Corp
(1.34 trillion Dong [US$58.81 million]
OPC Pharmaceutical JSC
(961.73 billion Dong [US$42.22 million]
During the year ended December of 2017, sales at
Imexpharm Corp were 1.17 trillion Dong (US$51.16 million).
increase of 15.4%
versus 2016, when the company's sales were 1.01 trillion Dong.
This was the fifth consecutive year of sales increases at Imexpharm Corp
(and since 2012, sales have increased a total of 42%).